Join Hesperos at the 2026 MPS World Summit in Washington, DC
If you are attending the MPS World Summit (Washington, DC, 26 – 29 May 2026), please stop by Booth 523 to learn more about how Hesperos’ Human-on-a-Chip® (HoaC) single- and multi-organ platform system technology is fundamentally changing the landscape of preclinical development and improving clinical trial outcomes.
HoaC single and multi-organ system platforms can:
Accelerating Timelines: Progress your preclinical assets (including repurposed and repositioned agents) faster than conventional in vivo testing timelines.
- Better Insights: HoaC platform model systems provide more comprehensive and informative, human-relevant data
Improving Predictivity: Using human cell and tissue constructs provides directly translatable information that can de-risk your clinical development.
Track Record of Success: Data generated from our HoaC platform model systems have been used in support of multiple INDs
Hesperos in the Scientific Program
We have a packed schedule featuring three major speaking sessions and nine poster presentations. Mark your calendars for these deep dives into the future of HoaC technology.
Oral Presentations & Sessions
| Date | Time | Session | Presentation Title | Speaker |
|---|---|---|---|---|
| Wednesday May 27 | 2:30–4:00pm | 1.3 | Development of a Digital Twin for Opioid Overdose Treatment | Aakash Patel, PhD |
| Wednesday May 27 | 2:30–4:00pm | 4.3 | Replacing Non-Rodent Species with Multi-Organ MPS | Christopher McAleer, PhD |
| Thursday May 28 | 2:30–4:00pm | 2.5 | Session Chair: Modeling Human Disease: Rare Diseases | Rocky Brighton |
| Thursday May 28 | 2:30–4:00pm | 4.5 | Regulatory Acceptance Case Studies: Developer–Regulator Dialogues (Tandem Presentations) “A CMT2S Human-on-a-Chip® Model to Evaluate Personalized Medicine” | Walker Hagan, PhD Co-presented with: |
Poster Presentations
Explore our latest research during the poster sessions. Our scientists will be available to discuss everything from cardiac stress tests to autoimmune models.
| Date | Time | Poster # | Presentation Title | Speaker |
|---|---|---|---|---|
| Wednesday May 27 | 9:30–11:00am | 340 | Human cardiac stress-test-on-a-chip | Christopher Long, PhD |
| Wednesday May 27 | 3:15–4:45pm | 175 | Unified CNS/PNS hiPSC-derived Model | Andrew Antolic, PhD |
| Wednesday May 27 | 3:15–4:45pm | 257 | Evaluating Neurocognitive Impairment & Efficacy | Kaveena Autar, PhD |
| Wednesday May 27 | 3:15–4:45pm | 299 | Autoimmune-Mediated Peripheral Neuropathies | Deepshikha Mitra |
| Thursday May 28 | 10:00–11:30am | 328 | NMJ Platform for Efficacy and Toxicity | Hannah Hanson |
| Thursday May 28 | 4:00–5:30pm | 227 | Automated NMJ Functional Assessment Platform | Chase Miller |
| Thursday May 28 | 4:00–5:30pm | 297 | Botulinum Neurotoxin Potency Evaluation | Lawrence Florin |
| Thursday May 28 | 4:00–5:30pm | 299 | Metabolism Effects for the NK-1 Antagonist Tradipitant | Rocky Brighton |
| Thursday May 28 | 4:00–5:30pm | 325 | Distributed Video Acquisition for NMJ Platforms | Singith Abeysiriwardena, PhD |